search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
28


New Flow Cytometry Software Enables High Throughput Determination of Apoptotic Mechanism


Julie Clor, Kimvan Tran, Roberto Renteria, Rick Pittaro, and Kamala Tyagarajan Millipore Corporation, Hayward, CA


INTRODUCTION


The study of the role of mitochondria in cell health and apoptosis has become increasingly important. Here, we study the inter-relationships between mitochondrial membrane potential, apoptosis, cell death and mitochondrial superoxide stress using the multiplexing power of the guava easyCyte 8HT benchtop flow cytometry platform and Incyte software when cells are treated with multiple inducers


Using the guava® easyCyte™ 8HT flow cytometer with InCyte™ software (Millipore) and the FlowCellect™ MitoDamage Kit (Millipore), we


demonstrate that simultaneous dose-response data can be obtained on mitochondrial membrane potential change, apoptosis and cell death using inducers such as staurosporine. Further, the MitoStress Kit demonstrates that stauropsorine also induces an increase in mitochondrial superoxide stress and apoptosis almost simultaneously, which is in agreement with the current literature on mode of staurosporine action.


ADVERTORIAL


METHODS


The FlowCellect MitoDamage kit includes: MitoSense Red, which is responsive to mitochondrial potential changes; CF488A-conjugated Annexin V, which binds to phosphatidylserine (PS) on the surface of apoptotic cells; and 7AAD, a membrane-impermeant dead cell dye. Cellular mitochondrial potential changes cause a shift from high Red2 to low Red2 fluorescence. Increased phosphotidylserine exposure causes an increase in green fluorescence. Increased necrosis results in increased red fluorescence.


Jurkat cells were treated with multiple concentrations of inducers such as diamide and staurosporine; treated with kit reagents; and analysed on the guava easyCyte 8HT instrument. Heat maps and EC50 curves were easily generated (Figure 1) within the InCyte software enabling simultaneous comparison of multiple data sets.


RESULTS AND CONCLUSIONS


Our data demonstrate how the combination of InCyte software with MitoDamage kits gives flow cytometry users the power to quickly draw conclusions about the biological significance of multi-parametric apoptosis data. The combination also enables responses for the same sample to be compared across multiple reagents, which is highly valuable in time-based and dose-based tracking.


Increased concentrations of staurosporine resulted in dissipation of mitochondrial membrane potential and entry into apoptosis (as measured by Annexin V binding). The EC50 values for both mitochondrial membrane change and Annexin V binding were very similar with EC50 of 0.45 uM and 0.43 uM, respectively, demonstrating that simultaneous analysis of these parameters allows for greater precision in measurements. The coincidence of these two phenotypes provides support for the biological linkage of staurosporine- mediated apoptosis to changes in mitochondrial membrane potential. Further research is required to determine the precise pathway by which inducers such as staurosporine and diamide result in mitochondria-associated apoptosis.


Figure 1. Correlation of mitochondrial potential with staurosporine- induced apoptosis. Treatment of Jurkat cells with staurosporine followed by staining with the FlowCellect MitoDamage Kit allowed for simple generation of a heat map (A), dot plots (B), and dose response curves with EC50 values for mitochondrial membrane potential change and Annexin V binding (C).


Circle no. 59


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208  |  Page 209  |  Page 210  |  Page 211  |  Page 212  |  Page 213  |  Page 214  |  Page 215  |  Page 216  |  Page 217  |  Page 218  |  Page 219  |  Page 220